diphenyl/obesity

FIELD OF THE INVENTION The present invention relates to novel diphenyl ether derivatives of formula (I), their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable

FIELD OF THE INVENTION The present invention relates to novel heterocyclic compounds of the general formula (I), derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, pharmaceutically acceptable salts and pharmaceutically acceptable solvates thereof, and pharmaceutically

The cannabinoid CB-1 receptor (CB-1) is primarily found in the central and peripheral nervous systems and to a lesser extent in several peripheral organs. The cannabinoid CB-2 receptor (CB-2) is found primarily in the immune system. The pharmacology and therapeutic potential for cannabinoid receptor

The cannabinoid CB-1 receptor (CB-1) is primarily found in the central and peripheral nervous systems and to a lesser extent in several peripheral organs. The cannabinoid CB-2 receptor (CB-2) is found primarily in the immune system. The pharmacology and therapeutic potential for cannabinoid receptor

The invention relates to novel diphenyl derivatives, to processes for their preparation and to their use in medicaments. EP-A-580 550 describes oxamic acid derivatives having cholesterol-lowering properties in mammals. The pharmacological property that is emphasized is the reduction of plasma

FIELD OF THE INVENTION The present application is directed to various compounds and methods of preparation of compounds that are capable of functioning as cannabinoid receptor 1 (CB1) antagonists. The application is also directed to pharmaceutical compositions containing one or more of these

FIELD OF THE INVENTION The present application is directed to various compounds and methods of preparation of compounds that are capable of functioning as cannabinoid receptor 1 (CB1) antagonists. The application is also directed to pharmaceutical compositions containing one or more of these

BACKGROUND OF THE INVENTION Marijuana (Cannabis sativa L.) and its derivatives have been used for centuries for medicinal and recreational purposes. A major active ingredient in marijuana and hashish has been determined to be .DELTA..sup.9-tetrahydrocannabinol (.DELTA..sup.9-THC). Detailed research

BACKGROUND OF THE INVENTION Marijuana (Cannabis sativa L.) and its derivatives have been used for centuries for medicinal and recreational purposes. A major active ingredient in marijuana and hashish has been determined to be .DELTA..sup.9-tetrahydrocannabinol (.DELTA..sup.9-THC). Detailed research